Document Detail


Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics.
MedLine Citation:
PMID:  12526947     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Although there is growing interest in irritable bowel syndrome (IBS) research, there is as yet no consensus regarding the preferred outcome measure. We aimed to evaluate and to compare the validity and appropriateness of available IBS outcome measures. METHODS: IBS symptom and IBS health-related quality of life (HRQOL) scales were identified through a literature search. In a panel evaluation, six reviewers independently rated the scales according to predetermined psychometric and methodological validation criteria. RESULTS: Five IBS symptom scales and five IBS HRQOL instruments were identified. Two of the symptom scales were rated as good. The Adequate Relief question scored best. This scale demonstrates responsiveness as well as face and construct validity, and its score was considered easy to interpret and appropriate for use. According to the reviewers, the IBS Severity Scoring System performed well with regard to psychometric capacities, but its practical utility was considered debatable. The properties of the other three symptom scales were suboptimal. The practical utility of the five IBS-specific HRQOL scales was considered poor. However, the reviewers agreed that, at present, the IBS Quality of Life measurement (Patrick et al.) is the best choice, because it has been the most extensively validated and shows appropriate psychometric quality. CONCLUSIONS: The Adequate Relief question is the measure of first choice when assessing global symptomatology as an outcome in IBS studies. For a more detailed IBS symptom assessment, the IBS Severity Scoring System is preferable. Finally, the IBS Quality of Life measurement scale can be used to establish changes in health-related quality of life.
Authors:
C J Bijkerk; N J de Wit; J W M Muris; R H Jones; J A Knottnerus; A W Hoes
Related Documents :
17521397 - Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predomin...
22328957 - Clindamycin phosphate 1.2% and benzoyl peroxide 2.5% gel for the treatment of moderate-...
23826887 - Systematic tailoring for the implementation of guideline recommendations for anxiety an...
16185307 - A randomized controlled trial of a probiotic combination vsl# 3 and placebo in irritabl...
17876497 - Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind ran...
15259757 - Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Studies    
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  98     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-01-15     Completed Date:  2003-03-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  122-7     Citation Subset:  IM    
Affiliation:
Julius Center for General Practice and Patient Oriented Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Colonic Diseases, Functional / therapy*
Health Status Indicators*
Humans
Psychometrics
Quality of Life*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patie...
Next Document:  Decreased colonic motility in persons with chronic spinal cord injury.